“Preparation for the Sofdra Patient Experience Program is complete and ready for commencement. In collaboration with International Hyperhidrosis Society, highly qualified patients will initially be educated about Sofdra and then have the opportunity to gain early access to Sofdra. These first commercial users of the product will provide valuable feedback regarding the telemedicine and fulfillment processes, while Botanix will gain insights into optimization of these processes before they are exposed to significantly larger volumes of patients in Q1 CY2025.”
From email this morning patient. Experience is complete and ready to start - it’s beginning.
Ann: September 2024 Quarterly Activities Report and Appendix 4C, page-18
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
30.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $588.2M | |||
| Open | High | Low | Value | Volume |
| 30.5¢ | 31.0¢ | 30.0¢ | $2.131M | 7.020M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 18 | 504695 | 30.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.5¢ | 38124 | 3 |
View Market Depth
| Last trade - 16.10pm 24/06/2025 (20 minute delay) ? |
| BOT (ASX) Chart |